Banner image for CovalX epitope mapping services showing a 3D molecular surface model of an antibody-antigen interaction de novo sequencing
Epitope Mapping Service CovalX provides epitope mapping services using XL-MS and HDX-MS to characterize antibody binding sites and protein-protein interactions at the peptide level.

Ultraviolet–Visible Spectroscopy

Talk to Our Scientists

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Ultraviolet–visible spectroscopy (UV-Vis)

UV-Vis spectroscopy provides the concentration and purity inputs that precede every downstream analytical step. The quality of those measurements directly affects the reliability of what follows: formulation decisions, dose calculations, and comparability assessments depend on an accurate A280 reading and a clean spectral baseline. The technique is fast, reagent-free, and non-destructive, which is why it sits at the entry point of most biopharmaceutical characterization workflows.

How UV-Vis Works

UV-Vis spectroscopy quantifies the absorption of electromagnetic radiation in the ultraviolet and visible regions of the spectrum. Absorption arises from electronic transitions: photon energy promotes electrons from the ground state to higher energy orbitals. The relationship between absorbance and analyte concentration is governed by the Beer-Lambert law: A = ε × c × l, where ε is the molar extinction coefficient (L·mol⁻¹·cm⁻¹), c is concentration, and l is optical path length.

For biomolecules, proteins are commonly measured at 280 nm, where tryptophan, tyrosine, and phenylalanine act as chromophores. Protein concentration can be derived from A280 using a sequence-based extinction coefficient, and 260/280 and 260/230 ratios provide a rapid assessment of contamination by protein, phenol, salts, or other UV-active impurities.

Applications

Protein and antibody concentration confirmation

Once absorbance is measured at 280 nm, protein concentration is calculated using the Beer-Lambert law and the molar extinction coefficient. For monoclonal antibodies and bispecifics, this is a routine upstream measurement before downstream characterization by techniques such as SEC, mass spectrometry, or functional assays.

Purity and quality control

Absorbance ratios and full spectral profiles provide rapid, reagent-free purity assessments with no sample consumption. This makes UV-Vis a practical screen at batch release and during stability studies, before committing material to more resource-intensive downstream methods.

Protein aggregation monitoring

UV-Vis can detect light scattering contributions from particulate or aggregated species, which cause apparent increases in baseline absorbance across the UV range. This serves as a rapid, orthogonal indicator of aggregation status prior to more detailed characterization.

Technical Notes

Key practical considerations for UV-Vis measurements:

  • Buffer blanking must be performed with the exact formulation buffer. Absorbing excipients (e.g., certain detergents, DMSO) can contribute to the baseline at 280 nm and require correction.
  • Path length correction is required when using non-standard cuvettes or microvolume platforms. A 1 cm path length is the reference condition for Beer-Lambert calculations.
  • High-concentration samples (A280 > 2.0) fall outside the linear range of the Beer-Lambert law. Samples should be diluted to an absorbance between 0.1 and 1.0 for accurate results.
  • Sample heterogeneity: turbid or aggregated samples scatter light, which elevates apparent absorbance. Spectral inspection across the 320 to 400 nm region (where proteins do not absorb) identifies significant scattering contributions.

Regulatory Context

UV-Vis spectroscopy is recognized under ICH Q6B as a physicochemical characterization method for biotherapeutics, covering protein concentration determination and purity assessment. A280-based concentration data is routinely included in IND and BLA submissions as a primary identity and potency parameter. Absorbance measurements are also referenced in ICH Q2(R2) for method validation of quantitative procedures. UV-Vis purity assessments are accepted as supporting data in biosimilar comparability packages by both FDA and EMA.

One CRO, coordinated data

UV-Vis is part of CovalX’s biophysical characterization offering. It functions as an upstream measurement that feeds directly into other characterization workflows. Running concentration determination, biophysical profiling, and structural characterization through a single CRO reduces sample handling steps, eliminates inter-laboratory concentration discrepancies, and supports consolidated reporting for regulatory packages.
UV-Vis concentration and purity data feeds directly into CovalX’s biophysical and MS-based characterization workflows. Contact us to evaluate how UV-Vis measurements integrate with your current analytical program and regulatory package.

 

text
Talk to Our Scientists

Our team is available to answer any of your questions about our products and services